Empire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosis.

Saved in:
Bibliographic Details
Title: Empire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosis.
Authors: Elborn JS; Faculty of Medicine Health and Life sciences Queens University School of Medicine, Belfast, UK., Konstan MW; Department of Pediatrics, Case Western Reserve University School of Medicine and Rainbow Babies & Children's Hospital, Cleveland, OH, USA., Taylor-Cousar JL; Departments of Medicine and Pediatrics, National Jewish Health, Denver, CO, USA., Fajac I; Physiology Department, Cochin Hospital, APHP Centre, Paris, France; Université de Paris, Paris, France., Horsley A; Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Sutharsan S; Division of Cystic Fibrosis, Department of Pulmonary Medicine, University Medicine EssenRuhrlandklinik, University of DuisburgEssen, Essen, Germany., Aaron SD; Ottawa Health Research Institute, Ottawa, Ontario, Canada., Daines CL; Department of Pediatrics, University of Arizona, Tucson, AZ, USA., Uluer A; Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Downey DG; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK., Lucidi VV; Cystic Fibrosis Center, Children's Hospital and Research Institute, Bambino Gesu, Rome, Italy., Ahuja S; Celtaxsys, Inc., Atlanta, GA, USA., Springman E; Celtaxsys, Inc., Atlanta, GA, USA., Mershon J; Celtaxsys, Inc., Atlanta, GA, USA., Grosswald R; Celtaxsys, Inc., Atlanta, GA, USA., Rowe SM; Gregory Fleming James Cystic Fibrosis Research Center and Department of Medicine, University of Alabama at Birmingham, 1918 University Blvd, MCLM 804, Birmingham 35294, AL, USA. Electronic address: smrowe@uab.edu.
Corporate Authors: EMPIRE-CF study group
Source: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2021 Nov; Vol. 20 (6), pp. 1026-1034. Date of Electronic Publication: 2021 Sep 17.
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128966 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5010 (Electronic) Linking ISSN: 15691993 NLM ISO Abbreviation: J Cyst Fibros Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-5010
DOI:10.1016/j.jcf.2021.08.007